JUN and neoplasm: Using IHC, Jin et al. showed that JUN was down-regulated and had tumor suppressor activity in GC. The loss of JUN expression was correlated to a more advanced stage, lymphatic invasion, lymph node metastasis, and shorter survival of GC patients